¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
6/4 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2022-06-02
Á¶È¸¼ö
174


¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ´ÙÁ¤ÀÔ´Ï´Ù.
Á¦°¡ À̹ø¿¡ ¼±Á¤ÇÑ ³í¹®Àº 2020³â JEM¿¡ ÃâÆǵÈ
'Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection.' ÀÔ´Ï´Ù.

À§ ³í¹®Àº chronic viral infection »óȲ¿¡¼­ small intestine¿¡ Á¸ÀçÇÏ´Â hematopoietic, mesenchymal cell¿¡¼­ virus replicationÀÌ Áö¼ÓÀûÀÌ ÀϾÀ» È®ÀÎÇÏ¿´°í,
ÀÌ´Â intestineÀÇ barrier permeability¸¦ Áõ°¡½ÃÄÑ °á·ÐÀûÀ¸·Î secondary chemical ȤÀº microbial intestinal insults¿¡ ´ëÇÑ Áõ°¡µÈ mortality °á°ú¸¦ °¡Áö°í ¿ÈÀ» È®ÀÎÇÑ ³í¹®ÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ °á°ú¸¦ °¡Á®¿Â ¸ÅÄ¿´ÏÁòÀ¸·Î½á´Â chronic virus infection¿¡ ÀÇÇÑ type I IFN signalingÀÌ tight junction dysregulation, CD8 T cell accumulation/effector fucntion, intestinal microbiome changes¸¦ ¾ß±âÇϸ鼭 »ý±ä °á°ú·Î ¼³¸íÇÏ°í ÀÖ½À´Ï´Ù. 

À§ ³í¹®Àº Á¦ ¿¬±¸¿¡¼­ virus infection »óȲ¿¡¼­ mLN¿¡¼­ÀÇ ´Ù¸¥ °æÇ⼺¿¡ ´ëÇؼ­ °øºÎÇϱâ À§Çؼ­ virus infection°ú intestine°úÀÇ °ü°è¿¡ ´ëÇÑ °øºÎ¸¦ ÇÏ°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù. 

¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.

´ÙÁ¤¿Ã¸². 

³í¹® ¸µÅ© : https://rupress.org/jem/article/217/12/e20192276/152069/Type-I-IFNs-and-CD8-T-cells-increase-intestinal
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
6/4 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä Á¤Ã¶ÀÔ´Ï´Ù. Á¦°¡ À̹ø ÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº 2022³â 3¿ù Mucosal immunology¿¡ ÃâÆÇµÈ 'Vitamin D receptor upregulates tight junction protein claudin-5 against colitis-associated tumorigenesis'ÀÔ´Ï´Ù. VDR signalingÀÌ epithelial barrier function¿¡ ¸¹Àº °ü¿©¸¦ ÇÏ°í ÀÖ´Ù´Â Á¡Àº ¾Ë·ÁÁ®..
ÀÌÀü±Û
5/28 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. ±â¼± ÀÔ´Ï´Ù. Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº Immunity¿¡ 2022³â¿¡ ÃâÆÇµÈ 'The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis'ÀÔ´Ï´Ù. Gut microbiota°¡ bacteria ¹× fungal infection¿¡ Áß¿äÇÏ´Ù´Â °ÍÀº ÀÌ¹Ì ¸¹ÀÌ ¾Ë·ÁÁ® ÀÖÀ¸¸ç º» ¿¬±¸¿¡¼­´Â gut microbiota°¡ v..